Two novel spiramycins obtained from commercial samples: isolation and elucidation of structure.
Liu
L
L
Katholieke Universiteit Leuven, Laboratorium voor Farmaceutische Chemie en Analyse van Geneesmiddelen, Faculteit Farmaceutische Wetenschappen, Belgium.
Roets
E
E
Busson
R
R
Vankeerberghen
A
A
Janssen
G
G
Hoogmartens
J
J
D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000494:pharmacology; D001412:Bacillus subtilis / Q000187:drug effects; D002240:Carbohydrate Sequence; D002851:Chromatography, High Pressure Liquid; D009682:Magnetic Resonance Spectroscopy; D013058:Mass Spectrometry / Q000379:methods; D008969:Molecular Sequence Data; D015394:Molecular Structure; D015572:Spiramycin / Q000031:analogs & derivatives* / Q000737:chemistry* / Q000302:isolation & purification / Q000494:pharmacology; D013302:Streptomyces / Q000378:metabolism
D000900:Anti-Bacterial Agents; C090280:neospiramycin; D015572:Spiramycin